About the Study

The purpose of this study is to find out if d-cycloserine improves the effectiveness of cognitive behavioral therapy (CBT) in reducing symptoms associated with social anxiety disorder. D-cycloserine is a cognitive enhancer that may enhance the learning that takes place during therapy.

What Does the Study Involve?

This study involves:

·         Questionnaire completion

·         Psychiatric interview

·         Group program to help you with your fear of embarrassment

·         2 follow up visits

Each study visit will take a few hours, and will take place in our clinic at Boston University. Participants will receive financial compensation for some of these visits. Treatment will be at no cost and be delivered by qualified therapists.

Who is the Study for?

This is a study for adults in the Boston area who are suffering from Social Anxiety Disorder, which is a condition characterized by severe and uncontrollable worry and anxiety in social situations. Click here to read more about Social Anxiety Disorder.

This study is not suited for people who are primarily interested in compensation. This study is for people who have difficulties with worry and anxiety and are interested in getting treatment for those problems.

Who We Are

This study is being conducted at the Psychotherapy and Emotion Research Laboratory of the Center for Anxiety and Related Disorders at Boston University. The research is led by Dr. Stefan Hofmann, Ph.D.

This study is funded by the National Institute of Mental Health (NIMH).